IDERA

Welcome to the Brand page for “IDERA”, which is offered here for The mark consists of the word idera and a design element. the design element is positioned above and to the left of the word idera and consists of six circles around a common center. four of those circles are connected to matching circles such that they resemble cells that are in the act of splitting. one of the two other circles forms the dot in the letter i in idera.;medical therapeutic preparations, biologically active modulators, biologically active immune modulators, biologically active antisense dna or rna compounds, chemical modulators of gene expression working at dna transcription, rna or translation processes; immunomodulatory oligonucleotides, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “IDERA” is believed to be currently owned by “IDERA PHARMACEUTICALS, INC.”

Owner:
IDERA PHARMACEUTICALS, INC.
Owner Details
Description:
The mark consists of the word IDERA and a design element. The design element is positioned above and to the left of the word IDERA and consists of six circles around a common center. Four of those circles are connected to matching circles such that they resemble cells that are in the act of splitting. One of the two other circles forms the dot in the letter I in IDERA.;Medical therapeutic preparations, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes;Color is not claimed as a feature of the mark.;
Categories: